Adiponectin serum levels and their relationships to androgen concentrations and ovarian volume during puberty in girls with type 1 diabetes mellitus

Hormone Research

Volumn 70, Issue 2, 2008, Pages 112-117

  Iñiguez, Germán ^a   Torrealba, Isabel M ^b   Avila, Alejandra ^a   Cassorla, Fernando ^a   Codner, Ethel ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL LUIS CALVO MACKENNA   (Chile)

Author keywords

Adiponectin; Hyperandrogenism; Puberty; Type 1 diabetes mellitus

Indexed keywords

ADIPONECTIN; HEMOGLOBIN A1C; INSULIN; TESTOSTERONE; ADIPONECTIN, HUMAN;

ADOLESCENT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; OVARY; PRIORITY JOURNAL; PUBERTY; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SCHOOL CHILD; SEXUAL MATURATION; TESTOSTERONE BLOOD LEVEL; BLOOD; CHILD; ECHOGRAPHY; HISTOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPONECTIN; ADOLESCENT; BODY MASS INDEX; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; OVARY; PUBERTY; REGRESSION ANALYSIS; TESTOSTERONE;

EID: 54449099395     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000137656     Document Type: Article

References (32)

1. Svensson M, Nyström L, Schön S, Dahlquist G: Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study. Diabetes Care 2006;29:538-542.
2. Cummings EA, Sochett EB, Dekker MG, Lawson ML, Daneman D: Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes 1998;47:1341-1346.
3. Bryden KS, Peveler RC, Stein A, Neil A, Mayou RA, Dunger DB: Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study. Diabetes Care 2001;24:1536-1540.
4. Codner E, Mook-Kanamori D, Bazaes RA, Unanue N, Sovino H, Ugarte F, Avila A, Iñiguez G, Cassorla F: Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide. J Clin Endocrinol Metab 2005;90:3939-3945.
5. Holl RW, Grabert M, Sorgo W, Heinze E, Debatin KM: Contributions of age, gender and insulin administration to weight gain in subjects with IDDM. Diabetologia 1998;41:542-547.
6. Codner E, Barrera A, Mook-Kanamori D, Bazaes RA, Unanue N, Gaete X, Avila A, Ugarte F, Torrealba I, Pérez V, Panteón E, Cassorla F: Ponderal gain, waist-to-hip ratio, and pubertal development in girls with type-1 diabetes mellitus. Pediatr Diabetes 2004;5:182-189.
7. Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB: Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 2001;86:1188-1193.
8. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996;221:286-289.
9. Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T: Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab 2004;89:87-90.
10. Lee S, Bacha F, Gungor N, Arslanian SA: Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care 2006;29:51-56.
11. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-58.
12. Perseghin G, Lattuada G, Danna M, Sereni LP, Maffi P, De Cobelli F, Battezzati A, Secchi A, Del Maschio A, Luzi L: Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2003;285:E1174-E1181.
13. Imagawa A, Funahashi T, Nakamura T, Moriwaki M, Tanaka S, Nishizawa H, Sayama K, Uno S, Iwahashi H, Yamagata K, Miyagawa J, Matsuzawa Y: Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002;25:1665-1666.
14. Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH: Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 2005;28:1410-1414.
15. Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A: Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005;48:1911-1918.
16. Costacou T, Zgibor JC, Evans RW, Otvos J, Lopes-Virella MF, Tracy RP, Orchard TJ: The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2005;48:41-48.
17. Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson JE, Ehrlich J, Eckel RH, Rewers M: Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 2005;111:747-753.
18. Böttner A, Kratzsch J, Müller G, Kapellen TM, Blüher S, Keller E, Blüher M, Kiess W: Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004;89:4053-4061.
19. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002;103:137-142.
20. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002;51:2734-2741.
21. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL: Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60.
22. Marshall WA, Tanner JM: Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
23. Iñiguez G, Soto N, Avila A, Salazar T, Ong K, Dunger D, Mericq V: Adiponectin levels in the first two years of life in a prospective cohort: relations with weight gain, leptin levels and insulin sensitivity. J Clin Endocrinol Metab 2004;89:5500-5503.
24. Codner E, Soto N, López P, Trejo L, Avila A, Eyzaguirre FC, Iñiguez G, Cassorla F: Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2006;91:2250-2256.
25. Vermeulen A, Verdonck L, Kaufman JM: A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
26. Swanson M, Sauerbrei EE, Cooperberg PL: Medical implications of ultrasonically detected polycystic ovaries. J Clin Ultrasound 1981;9:219-222.
27. Abke S, Neumeier M, Weigert J, Wehrwein G, Eggenhofer E, Schäffler A, Maier K, Aslanidis C, Schölmerich J, Buechler C: Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes. Cardiovasc Diabetol 2006;5:17.
28. Celi F, Bini V, Papi F, Santilli E, Castellani MS, Ferretti A, Mencacci M, Berioli MG, De Giorgi G, Falorni A: Circulating adipocytokines in non-diabetic and type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabet Med 2006;23:660-665.
29. Schalkwijk CG, Chaturvedi N, Schram MT, Fuller JH, Stehouwer CD: Adiponectin is inversely associated with renal function in type 1 diabetic patients. J Clin Endocrinol Metab 2006;91:129-135.
30. Morales A, Wasserfall C, Brusko T, Carter C, Schatz D, Silverstein J, Ellis T, Atkinson M: Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care 2004;27:2010-2014.
31. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, Chen B, Lam MC, Tse C, Cooper GJ, Lam KS: Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005;280:18073-18080.
32. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS, Scherer PE: Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003;52:268-276.